Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

PJET , PRTH , PRIF.P.D , PRIF.P.F , PRIF.P.I , PRIF.P.K , AAA
Sort by: Date|Relevance

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

The Rocks Teach You Where You Need to Go

(Click to play video.) Canadian based mineral exploration Company Labrador Gold Corp. ( TSX-V: LAB , OTCQX: NKOSF , Forum ) is focused on the acquisition and exploration of prospective gold projects in Eastern Canada. Its flagship mineral property is the Kingsw...
Featured Submission | October 19, 2020 |

Analyst Report Values Gold Junior 239% Over Current Price

Vancouver-based junior exploration Company Etruscus Resources Corp. ( CSE: ETR , OTC: ETRUF , Forum ) was recently covered by TSXV Research , looking at its Rock and Roll and Sugar properties located in the prolific Golden Triangle region of British Columbia, which boasts...
Featured Submission | January 12, 2021 |

Barrian Mining defines +1 km geophysical anomaly

On May 24 th , 2019, Barrian Mining Corp. (TSX-V: BARI) released details of their IP(induced polarization)/resistivity survey results on the Nevada based Bolo property located about 90 km northeast of Tonopah. Of course, in any mining project, the sun doesn’t...
Dr. Kal Kotecha | June 4, 2019 |

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

Shares of Cerecor Inc. are trading higher today after reporting that it will sell its pediatric portfolio to Aytu BioScience for $32 million in a combination cash and stock deal. Biopharmaceutical company Cerecor Inc. (CERC:NASDAQ) , which focuses on development and ...
Streetwise Reports | October 16, 2019 |

Lithium Chile: Building a Large Lithium Producer in Chile

(Click image to play video.) Large diversified lithium portfolio Lithium Chile ( TSX-V: LITH ) owns fourteen projects on Li-rich salars in Chile, making it the largest landholder of lithium salars outside the Chilean govt. and SQM. The portfolio includes 166,150 h...
Featured Submission | May 12, 2021 |

Biopharma Expected to Bring 'Two First-in-Class Antibiotics to Market in 2019'

The likely timelines for approval and commercialization of each drug are discussed in an H.C. Wainwright report. In a March 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that Nabriva Therapeutics Plc (NBRV:NASDAQ) has two antibiotics up for approval...
Streetwise Reports | March 21, 2019 |

NewLink Genetics Shares Shoot Higher after FDA Ebola Vaccine Approval

Shares of NewLink Genetics got a boost today after the firm reported that the FDA approved its ERVEBO V920 vaccine used in the treatment of Zaire Ebola virus. The company's shares set a new 52-week high price in mid-morning trading. This morning after the U.S. markets...
Streetwise Reports | December 23, 2019 |

Buzz on the Bullboards: Bombardier, Baytex and Tilray turn heads

North American stocks have had a strong week. Markets on both sides of the border responded well to the U.S. Federal Reserve’s vote to hold interest rates between 5.25 per cent and 5.50 per cent for a fifth straight meeting. The central bank has kept r...
Jonathon Brown | March 21, 2024 |
1 2 3 4 5 6 7 8 9 10 ...